Literature DB >> 8842417

Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens.

G J Chang1, M H Wu, Y C Wu, M J Su.   

Abstract

1. The antiarrhythmic potential and electromechanical effects of liriodenine, an aporphine alkaloid isolated from the plant, Fissistigma glaucescens, were examined. 2. In the Langendorff perfused (with constant pressure) rat heart, at a concentration of 0.3 to 3 microM, liriodenine was able to convert a polymorphic ventricular tachyrhythmia induced by the ischaemia-reperfusion (EC50 = 0.3 microM). 3. In isolated atrial and ventricular muscle, liriodenine increased the contractile force and slowed the spontaneous beating of the right atrium. 4. The liriodenine-induced positive inotropy was markedly attenuated by a transient outward K+ channel blocker, 4-aminopyridine (4-AP) but was not significantly affected by prazosin, propranolol, verapamil or carbachol. 5. In rat isolated ventricular myocytes, liriodenine prolonged action potential duration and decreased the maximal upstroke velocity of phase 0 depolarization (Vmax) and resting membrane potential in a concentration-dependent manner. The action potential amplitude was not significantly changed. 6. Whole-cell voltage clamp study revealed that liriodenine blocked the Na+ channel (INa) concentration-dependently (IC50 = 0.7 microM) and caused a leftward shift of its steady-state inactivation curve. However, its recovery rate from the inactivated state was not affected. The L-type Ca2+ currents (Ica) were also decreased, but to a lesser degree (IC50 = 2.5 microM, maximal inhibition = 35%). 7. Liriodenine inhibited the 4-AP-sensitive transient outward current (Ito) (IC50 = 2.8 microM) and moderately accelerated its rate of decay. The block of Ito was not associated with changes in the voltage-dependence of the steady-state inactivation curve or in the process of recovery from inactivation of the current. Liriodenine also reduced the amplitude of a slowly inactivating, steady-state outward current (Iss) (IC50 = 1.9 microM). These effects were consistent with its prolonging effect on action potential duration. The inwardly rectifying background K+ current (IK1), was also decreased but to a less degree. 8. Compared to quinidine, liriodenine exerted a stronger degree of block on INa, comparable degree of block on IK1, and lesser extent of block on ICa and Ito. 9. It is concluded that, through inhibition of Na+ and the Ito channel, liriodenine can suppress ventricular arrhythmias induced by myocardial ischaemia reperfusion. The positive inotropic effect can be explained by inhibition of the Ito channel and the subsequent prolongation of action potential duration. These results provide a satisfactory therapeutic potential for the treatment of cardiac arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842417      PMCID: PMC1909826          DOI: 10.1111/j.1476-5381.1996.tb15577.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  A classification of antiarrhythmic actions reassessed after a decade of new drugs.

Authors:  E M Vaughan Williams
Journal:  J Clin Pharmacol       Date:  1984-04       Impact factor: 3.126

2.  Reperfusion-induced arrhythmias: mechanisms and prevention.

Authors:  A S Manning; D J Hearse
Journal:  J Mol Cell Cardiol       Date:  1984-06       Impact factor: 5.000

3.  Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. An effect on steady state sodium currents?

Authors:  T J Colatsky
Journal:  Circ Res       Date:  1982-01       Impact factor: 17.367

4.  Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac purkinje fibers. An effect on Na or K currents?

Authors:  E Carmeliet; T Saikawa
Journal:  Circ Res       Date:  1982-02       Impact factor: 17.367

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Early outward current in rat single ventricular cells.

Authors:  I R Josephson; J Sanchez-Chapula; A M Brown
Journal:  Circ Res       Date:  1984-02       Impact factor: 17.367

Review 7.  Electrophysiological changes and ventricular arrhythmias in the early phase of regional myocardial ischemia.

Authors:  M J Janse; A G Kléber
Journal:  Circ Res       Date:  1981-11       Impact factor: 17.367

8.  Sodium current depression by lidocaine and quinidine in isolated ventricular cells.

Authors:  K S Lee; J R Hume; W Giles; A M Brown
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

9.  Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine.

Authors:  H Nawrath
Journal:  J Pharmacol Exp Ther       Date:  1981-01       Impact factor: 4.030

10.  Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells.

Authors:  J Sanchez-Chapula; Y Tsuda; I R Josephson
Journal:  Circ Res       Date:  1983-05       Impact factor: 17.367

View more
  8 in total

1.  Mechanical effects of liriodenine on the left ventricular-arterial coupling in Wistar rats: pressure-stroke volume analysis.

Authors:  K C Chang; M J Su; Y I Peng; C C Shao; Y C Wu; Y Z Tseng
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.

Authors:  Gwo-Jyh Chang; Ming-Jai Su; Li-Man Hung; Shoei-Sheng Lee
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

3.  Screening an In-House Isoquinoline Alkaloids Library for New Blockers of Voltage-Gated Na+ Channels Using Voltage Sensor Fluorescent Probes: Hits and Biases.

Authors:  Quentin Coquerel; Claire Legendre; Jacinthe Frangieh; Stephan De Waard; Jérôme Montnach; Leos Cmarko; Joseph Khoury; Charifat Said Hassane; Dimitri Bréard; Benjamin Siegler; Ziad Fajloun; Harold De Pomyers; Kamel Mabrouk; Norbert Weiss; Daniel Henrion; Pascal Richomme; César Mattei; Michel De Waard; Anne-Marie Le Ray; Christian Legros
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

4.  Liriodenine enhances radiosensitivity in esophageal cancer ECA-109 cells by inducing apoptosis and G2/M arrest.

Authors:  Gang Wu; Guangzong Chen; Jialiang Zhou; Hongcheng Zhu; Jianjun Chu; Fuzheng Zhang
Journal:  Oncol Lett       Date:  2018-08-02       Impact factor: 2.967

5.  Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression.

Authors:  Liang Li; Ying Xu; Binquan Wang
Journal:  Oncol Lett       Date:  2014-12-29       Impact factor: 2.967

6.  Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression.

Authors:  Noraziah Nordin; Nazia Abdul Majid; Najihah Mohd Hashim; Mashitoh Abd Rahman; Zalila Hassan; Hapipah Mohd Ali
Journal:  Drug Des Devel Ther       Date:  2015-03-10       Impact factor: 4.162

Review 7.  Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence.

Authors:  Danesh Soltani; Bayan Azizi; Roja Rahimi; Azita H Talasaz; Hossein Rezaeizadeh; Ali Vasheghani-Farahani
Journal:  Front Cardiovasc Med       Date:  2022-09-29

8.  Interrelated In Vitro Mechanisms of Sibutramine-Induced Cardiotoxicity.

Authors:  Feyza Alyu; Yusuf Olgar; Sinan Degirmenci; Belma Turan; Yusuf Ozturk
Journal:  Cardiovasc Toxicol       Date:  2021-01-03       Impact factor: 3.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.